首页 | 本学科首页   官方微博 | 高级检索  
     

乳酸菌阴道胶囊联合硝呋太尔制霉菌素阴道软胶囊治疗妊娠期外阴阴道假丝酵母菌病的效果
引用本文:方国珍,陈健. 乳酸菌阴道胶囊联合硝呋太尔制霉菌素阴道软胶囊治疗妊娠期外阴阴道假丝酵母菌病的效果[J]. 中国医药导报, 2013, 10(27): 65-67
作者姓名:方国珍  陈健
作者单位:1. 浙江省萧山医院产科,浙江萧山,311200
2. 浙江省台州市恩泽医疗中心(集团)恩泽妇产医院妇产科,浙江台州,318050
基金项目:浙江省医学会临床科研基金项目(编号2012ZYC-A114).
摘    要:
目的 探讨乳酸菌阴道胶囊联合硝呋太尔制霉菌素阴道软胶囊治疗妊娠期外阴阴道假丝酵母菌病的效果.方法 将72例妊娠期外阴阴道假丝酵母菌病患者随机分为观察组和对照组,每组各36例.两组患者均予以硝呋太尔制霉菌素阴道软胶囊放人阴道,每晚1粒,连用7d.观察组加用乳酸菌阴道胶囊放入阴道,每晚2粒,连用7d.结果 观察组患者治疗后的临床总有效率(91.67%)明显优于对照组(69.44%) (x2=5.67,P<0.05).对照组和观察组治疗期间分别出现药物不良反应3例(8.33%)和5例(18.39%),症状均较轻,未予处理症状逐渐自行消失,未发生严重药物不良反应.两组治疗期间药物不良反应发生率比较差异无统计学意义(x-2=0.14,P>0.05).观察组患者治疗后3个月内总复发率(11.11%)明显低于对照组(36.11%)(x2=6.24,P< 0.05).结论 乳酸菌阴道胶囊联合硝呋太尔制霉菌素阴道软胶囊治疗妊娠期外阴阴道假丝酵母菌病的效果确切,安全性较好,能明显降低复发率.

关 键 词:外阴阴道假丝酵母菌病  妊娠期  乳酸菌阴道胶囊  硝呋太尔制霉菌素阴道软胶囊

Curative effect of Lacidophilin Vaginal Capsules combined with Nifuratel Nystatin Vaginal Soft Capsule Preparation of Enzyme on vulvovaginal candidiasis patients during the pregnancy
FANG Guozhen , CHEN Jian. Curative effect of Lacidophilin Vaginal Capsules combined with Nifuratel Nystatin Vaginal Soft Capsule Preparation of Enzyme on vulvovaginal candidiasis patients during the pregnancy[J]. China Medical Herald, 2013, 10(27): 65-67
Authors:FANG Guozhen    CHEN Jian
Affiliation:1.Department of Obstetrics, Xiaoshan Hospital, Zhejiang Province, Xiaoshan 311200, China; 2.Department of Obstetrics and Gynecology, Enze Maternity Hospital of Enze Medical Center (Group), Zhejiang Province, Taizhou 318050, China)
Abstract:
Objective To discuss the curative effect of Lacidophilin Vaginal Capsules combined with Nifuratel Nys- tatin Vaginal Soft Capsule Preparation of Enzyme on vulvovaginal candidiasis (VVC) patients during the pregnancy. Methods 72 cases of VVC patients during the pregnancy were divided into observation group and control group with 36 cases in each group. The patients in two groups were given Nifuratel Nystatin Vaginal Soft Capsule Preparation of Enzyme in the vagina by one tablet for one night for 7 days. Additionally, the patients in observation group were given Lacidophilin Vaginal Capsules in the vagina by two tablets for one night for 7 days. Results The clinical total efficien- cy of patients in observation group after the medical treatment (91.67%) was much higher than that in control group (69.44%) (X2=5.67,P 〈 0.05). 3 cases (8.33%) and 5 cases (18.39%) of adverse drug reaction (ADR) appeared in the patients in contrOl group and observation group during the medical treatment separately with light symptom not serious ADR, and the untreated symptoms disappear gradually. After comparing the ADR occurrence rates of patients in two groups, no statistical differences appeared (X2=0.14,P 〉 0.05). The general reoccurrence rate of patients in observation group (11.11%) was much lower than that in control group within 3 months after the medical treatment (36.11%) (X2= 6.24,P 〈 0.05). Conclusion Lacidophilin Vaginal Capsules combined with Nifuratel Nystatin Vaginal Soft Capsule Preparation of Enzyme has reliable effect on VVC patients during the pregnancy, with high security, which can also lower the reoccurrence rate.
Keywords:Vulvovaginal candidiasis  Pregnancy  Lacidophilin Vaginal Capsules  Nifuratel Nystatin Vaginal SoftCapsule Preparation of Enzyme
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号